FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Klaus Herfarth

Research Profile

Concepts & Ideas

Procedures

Disorders

Objects

Three-Dimensional Imaging

Co-author Network

Publications

TOP 3
Torsten Moser; Kai Schubert; Gabriele Sroka-Perez; Matthias Uhl; Jürgen Debus; Gregor Habl; Klaus K Herfarth; Christian P Karger
Clinical evaluation of a laser surface scanning system in 120 patients for improving daily setup accuracy in fractionated radiation therapy.
Matthias Uhl; Baukelien van Triest; Damien C Weber; Michael J Eble; Klaus K Herfarth; Theodore L De Weese
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
M Uhl; Jürgen Debus; G Habl; H Holger; Kai Schubert; Florian Sterzing; Klaus K Herfarth
Breast cancer and funnel chest. Comparing helical tomotherapy and three-dimensional conformal radiotherapy with regard to the shape of pectus excavatum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Klaus Herfarth (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Torsten Moser; Kai Schubert; Gabriele Sroka-Perez; Matthias Uhl; Jürgen Debus; Gregor Habl; Klaus K Herfarth; Christian P Karger
Clinical evaluation of a laser surface scanning system in 120 patients for improving daily setup accuracy in fractionated radiation therapy.
International journal of radiation oncology, biology, physics 2013;85(3):846-53.
2013: Matthias Uhl; Baukelien van Triest; Damien C Weber; Michael J Eble; Klaus K Herfarth; Theodore L De Weese
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013;106(2):215-9.
2012: M Uhl; Jürgen Debus; G Habl; H Holger; Kai Schubert; Florian Sterzing; Klaus K Herfarth
Breast cancer and funnel chest. Comparing helical tomotherapy and three-dimensional conformal radiotherapy with regard to the shape of pectus excavatum.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(2):127-35.
2012: Sonja Krause; Steffen Lissner; Kai Schubert; Sebastian Beck; Juergen Debus; Klaus K Herfarth; Susanta Hui; Florian Sterzing
Accelerated large volume irradiation with dynamic Jaw/Dynamic Couch Helical Tomotherapy.
Radiation oncology (London, England) 2012;7():191.
2012: Henrik Hauswald; Klaus K Herfarth; Kerstin A Kessel; Stefan Rieken; Jürgen Debus; Swantje Ecker; Stephanie E Combs
First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Radiation oncology (London, England) 2012;7():189.
2012: Sonja Krause; Dirk Neuhof; Florian Sterzing; Juergen Debus; Lutz Edler; Klaus K Herfarth
Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial.
BMC cancer 2012;12():504.
2012: Stephanie E Combs; Claudia Blattmann; Swantje Ecker; Klaus K Herfarth; Angelika Hoess; Oliver Jäkel; Alexandra Jensen; Kerstin A Kessel; Andreas E Kulozik; Eike Martin; Susanne Oertel; Olaf Witt; Jürgen Debus
Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.
Radiation oncology (London, England) 2012;7():170.
2012: Henrik Hauswald; Frank W Hensley; Klaus K Herfarth; Nathalie Rochet; Matthias Uhl; Felix Zwicker; Jürgen Debus; Marc Bischof
Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia.
Radiation oncology (London, England) 2012;7():118.
2012: Alexandra D Jensen; Karen Lossner; Jürgen Debus; Klaus K Herfarth; Anna Nikoghosyan; Marc W Münter
IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.
BMC cancer 2012;12():163.
2012: Katsura Kosaki; Stefan Rieken; Jürgen Debus; Swantje Ecker; Daniel Habermehl; Klaus K Herfarth; Oliver Jäkel; Stephanie E Combs
Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas.
Radiation oncology (London, England) 2012;7():44.
2011: Eva Maria Stoiber; Matthias Uhl; Rolf Bendl; Kristina Giske; Gregor Habl; Klaus K Herfarth; Kai Schubert; Florian Sterzing; Jürgen Debus
Local setup reproducibility of the spinal column when using intensity-modulated radiation therapy for craniospinal irradiation with patient in supine position.
International journal of radiation oncology, biology, physics 2011;81(5):1552-9.
2011: S Krause; Klaus K Herfarth
[Radiotherapy of prostate cancer].
Der Radiologe 2011;51(11):955-61.
2011: Anna Nikoghosyan; Daniela Schulz-Ertner; Bernd Didinger; Thomas Haberer; Klaus K Herfarth; Angelika Hoess; Oliver Jäkel; Alexandra D Jensen; Marc W Münter; Jürgen Debus
Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.
Acta oncologica (Stockholm, Sweden) 2011;50(6):784-90.
2011: Matthias Uhl; Jürgen Debus; Gregor Habl; Kai Schubert; Gabriele Sroka-Perez; Florian Sterzing; Klaus K Herfarth
CT-myelography for high-dose irradiation of spinal and paraspinal tumors with helical tomotherapy: revival of an old tool.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(7):416-20.
2011: Alexandra D Jensen; Marc W Münter; Michael Thomas; Peter E Huber; Helge G Bischoff; Jürgen Debus; Uwe Haberkorn; Renate Haselmann; Klaus K Herfarth
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial.
Cancer 2011;117(13):2986-94.
2011: Harald Rief; Thomas Bruckner; Klaus K Herfarth; Alexandra D Jensen; Jürgen Debus
Isometric muscle training of the spine musculature in patients with spinal bony metastases under radiation therapy.
BMC cancer 2011;11():482.
2011: Alexandra D Jensen; Anna Nikoghosyan; Jürgen Debus; Swantje Ecker; Malte Ellerbrock; Klaus K Herfarth; Marc W Münter
Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.
Radiation oncology (London, England) 2011;6():149.
2011: Felix Zwicker; Jürgen Debus; Peter E Huber; Gerald Major; Florian Sterzing; Benedict Swartman; Christian Thieke; Klaus-Josef Weber; Klaus K Herfarth
Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland.
Radiation oncology (London, England) 2011;6():62.
2011: Mathias Witzens-Harig; Manfred Hensel; Michael Unterhalt; Klaus K Herfarth
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial.
BMC cancer 2011;11():87.
2010: Florian Sterzing; Henrik Hauswald; Matthias Uhl; Hendrik Herm; Andreas Wiener; Klaus K Herfarth; Jürgen Debus; Robert Krempien
Spinal cord sparing reirradiation with helical tomotherapy.
Cancer 2010;116(16):3961-8.
2010: Holger Hof; Jacqueline Zgoda; Simeon Nill; Angelika Hoess; Annette Kopp-Schneider; Klaus K Herfarth; Jürgen Debus; Christian Plathow
Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy.
International journal of radiation oncology, biology, physics 2010;77(5):1369-74.
2010: Fabienne McClanahan; Thomas Hielscher; Michael Rieger; Manfred Hensel; Kai Neben; Jens Hillengass; Klaus K Herfarth; Anthony D Ho; Mathias Witzens-Harig
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy.
European journal of haematology 2010;85(1):11-9.
2010: Stephanie E Combs; Klaus K Herfarth; D Habermehl; J Debus
[Radiotherapy of hepatic metastases].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2010;81(6):526-32.
2010: Nathalie Rochet; Florian Sterzing; Alexandra D Jensen; Julien Dinkel; Klaus K Herfarth; Kai Schubert; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
International journal of radiation oncology, biology, physics 2010;76(5):1382-9.
2010: Florian Sterzing; Matthias Uhl; Henrik Hauswald; Kai Schubert; Gabriele Sroka-Perez; Yu Chen; Weiguo Lu; Rock Mackie; Jürgen Debus; Klaus K Herfarth; Gustavo Oliveira
Dynamic jaws and dynamic couch in helical tomotherapy.
International journal of radiation oncology, biology, physics 2010;76(4):1266-73.
2009: Holger Hof; Bernhard Rhein; Peter Haering; Annette Kopp-Schneider; Jürgen Debus; Klaus K Herfarth
4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;93(3):419-23.
2009: Silke Ulrich; Florian Sterzing; Simeon Nill; Kai Schubert; Klaus K Herfarth; Jürgen Debus; Uwe Oelfke
Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer.
Medical physics 2009;36(10):4702-10.
2009: Florian Sterzing; Jörn Kalz; Gabriele Sroka-Perez; Kai Schubert; Marc Bischof; Falk Roder; Jürgen Debus; Klaus K Herfarth
Megavoltage CT in helical tomotherapy - clinical advantages and limitations of special physical characteristics.
Technology in cancer research & treatment 2009;8(5):343-52.
2009: Felix Zibold; Florian Sterzing; Gabriele Sroka-Perez; Kai Schubert; Katja Wagenknecht; Gerald Major; Jürgen Debus; Klaus K Herfarth
Surface dose in the treatment of breast cancer with helical tomotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(9):574-81.
2009: Julien Dinkel; Christian Hintze; Ralf Tetzlaff; Peter E Huber; Klaus K Herfarth; Juergen Debus; Hans U Kauczor; Christian Thieke
4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(3):449-54.
2009: Jörn Kalz; Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jürgen Debus; Klaus K Herfarth
Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(4):241-7.
2009: Florian Sterzing; Thomas Welzel; Gabriele Sroka-Perez; Kai Schubert; Jürgen Debus; Klaus K Herfarth
Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(2):89-93.
2008: Florian Sterzing; Dirk Neuhof; Philipp Stroebel; Juergen Debus; Klaus K Herfarth
Sarcomatoid sarcoma of the scalp - helical tomotherapy as a new radiotherapy option.
European journal of dermatology : EJD 2008;18(6):731-2.
2008: Felix Zwicker; Klaus K Herfarth; Thomas Welzel; Sebastian Aulmann; Stefan Dithmar; Holger Hof; Jürgen Debus
Palliative radiotherapy of retrobulbar orbit metastases due to breast cancer.
Onkologie 2008;31(10):529-33.
2008: Angela Funk; Frank W Hensley; Robert Krempien; Dirk Neuhof; Michael van Kampen; Martina Treiber; Falk Roeder; Carmen Timke; Klaus K Herfarth; Peter Helmbold; Juergen Debus; Marc Bischof
Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
European journal of dermatology : EJD 2008;18(3):308-12.
2008: Nathalie Rochet; Florian Sterzing; Alexandra Jensen; Julien Dinkel; Klaus K Herfarth; Kai Schubert; Michael H R Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Helical tomotherapy as a new treatment technique for whole abdominal irradiation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(3):145-9.
2008: Florian Sterzing; Gabriele Sroka-Perez; Kai Schubert; Marc W Münter; Christian Thieke; Peter Huber; Jürgen Debus; Klaus K Herfarth
Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;86(2):251-7.
2008: F Zwicker; Klaus K Herfarth; J Debus
[Palliative radiotherapy for a retrobulbar metastasis from a urinary bladder carcinoma].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2008;105(2):170-2.
2008: Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jörn Kalz; Jürgen Debus; Klaus K Herfarth
Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(1):8-14.
2007: Florian Sterzing; Klaus K Herfarth; Jürgen Debus
IGRT with helical tomotherapy--effort and benefit in clinical routine.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183 Spec No 2():35-7.
2007: Marc Bischof; Jürgen Debus; Klaus K Herfarth; Thomas Muley; Jutta Kappes; Konstantina Storz; Hans Hoffmann
Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(12):679-84.
2007: Holger Hof; Angelika Hoess; Dieter Oetzel; Jürgen Debus; Klaus K Herfarth
Stereotactic single-dose radiotherapy of lung metastases.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(12):673-8.
2007: Holger Hof; Marc Muenter; Dieter Oetzel; Angelika Hoess; Jürgen Debus; Klaus K Herfarth
Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
Cancer 2007;110(1):148-55.
2007: Marc W Münter; Simone Hoffner; Holger Hof; Klaus K Herfarth; Uwe Haberkorn; Volker Rudat; Peter Huber; Jürgen Debus; Christian P Karger
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
International journal of radiation oncology, biology, physics 2007;67(3):651-9.
2007: Stephan Buse; Jens Bedke; M Kurosch; Axel Haferkamp; Andreas Unterberg; Klaus K Herfarth; Markus Hohenfellner
[Brain metastases in cases of renal cell carcinoma].
Der Urologe. Ausg. A 2007;46(1):36-9.
2006: Stephanie E Combs; Daniela Schulz-Ertner; Klaus K Herfarth; Robert Krempien; J Debus
[Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2006;77(12):1126-32.
2006: Klaus K Herfarth; Marc W Münter; Hermann-Josef Groene; Stefan Delorme; Peter Peschke; Jürgen Debus
Absence of tissue reaction after focal high-dose irradiation of rabbit liver.
Acta oncologica (Stockholm, Sweden) 2006;45(7):865-9.
2006: Alexandra D Jensen; Marc W Münter; H Bischoff; R Haselmann; Carmen Timke; Robert Krempien; Florian Sterzing; Simeon Nill; Steffen Heeger; Angelika Hoess; Uwe Haberkorn; Peter E Huber; Martin B Steins; Michael Thomas; Jürgen Debus; Klaus K Herfarth
Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518).
BMC cancer 2006;6():122.
2005: Martin Krix; Christian Plathow; Marco Essig; Klaus K Herfarth; J Debus; Hans-Ulrich Kauczor; Stefan Delorme
Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.
European radiology 2005;15(4):677-84.
2005: Robert Krempien; Marc Muenter; Peter E Huber; Simeon Nill; Helmut Friess; Carmen Timke; Bernd Didinger; P Buechler; Steffen Heeger; Klaus K Herfarth; Amir Abdollahi; Markus W Buchler; Jürgen Debus
Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].
BMC cancer 2005;5():131.
2004: Holger Hof; Klaus K Herfarth; J Debus
[Stereotactic irradiation of lung tumors].
Der Radiologe 2004;44(5):484-90.
2004: Marcus Henze; Ashour Mohammed; Heinz-Peter Schlemmer; Klaus K Herfarth; Simone Hoffner; Sabine Haufe; Walter Mier; Michael Eisenhut; Jürgen Debus; Uwe Haberkorn
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):579-86.
2004: Klaus K Herfarth; Jürgen Debus; Michael Wannenmacher
Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial.
Frontiers of radiation therapy and oncology 2004;38():100-5.
2003: Klaus K Herfarth; Holger Hof; Malte L Bahner; Frank Lohr; Angelika Höss; Gerhard van Kaick; Michael Wannenmacher; Jürgen Debus
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors.
International journal of radiation oncology, biology, physics 2003;57(2):444-51.
2003: Holger Hof; Klaus K Herfarth; Marc W Münter; Marco Essig; Michael Wannenmacher; Jürgen Debus
The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(8):542-7.
2003: Klaus K Herfarth; Oxana Izwekowa; Christoph Thilmann; Andrea Pirzkall; Stefan Delorme; Udo Hofmann; Dirk Schadendorf; Dietmar Zierhut; Michael Wannenmacher; Jürgen Debus
Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(6):366-71.
2003: Holger Hof; Klaus K Herfarth; Marc W Münter; Angelika Hoess; Johann Motsch; Michael Wannenmacher; Jürgen Debus J
Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC).
International journal of radiation oncology, biology, physics 2003;56(2):335-41.
2002: Daniela Schulz-Ertner; Claudia Frank; Klaus K Herfarth; Bernhard Rhein; Michael Wannenmacher; Jürgen Debus
Fractionated stereotactic radiotherapy for craniopharyngiomas.
International journal of radiation oncology, biology, physics 2002;54(4):1114-20.
2002: Marcus Henze; Ashour Mohammed; Heinz-Peter Schlemmer; Klaus K Herfarth; Walter Mier; Michael Eisenhut; Jürgen Debus; Uwe Haberkorn
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
European journal of nuclear medicine and molecular imaging 2002;29(11):1455-61.
2002: Heinz-Peter Schlemmer; Peter Bachert; Marcus Henze; R Buslei; Klaus K Herfarth; Jürgen Debus; G van Kaick
Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy.
Neuroradiology 2002;44(3):216-22.
2002: Christoph Thilmann; Daniela Schulz-Ertner; Angelika Zabel; Klaus K Herfarth; Michael Wannenmacher; Jürgen Debus
Intensity-modulated radiotherapy of sacral chordoma--a case report and a comparison with stereotactic conformal radiotherapy.
Acta oncologica (Stockholm, Sweden) 2002;41(4):395-9.
2001: Heinz-Peter Schlemmer; Peter Bachert; Klaus K Herfarth; I Zuna; J Debus; G van Kaick
Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
AJNR. American journal of neuroradiology 2001;22(7):1316-24.
2001: Klaus K Herfarth; Sybille Gutwein; Jürgen Debus
Postoperative radiotherapy of astrocytomas.
Seminars in surgical oncology 2001;20(1):13-23.
2001: Klaus K Herfarth; Jürgen Debus; Frank Lohr; Malte L Bahner; Michael Wannenmacher
[Stereotactic irradiation of liver metastases].
Der Radiologe 2001;41(1):64-8.
2001: Klaus K Herfarth; Jürgen Debus; Frank Lohr; Malte L Bahner; Bernhard Rhein; P Fritz; Angelika Höss; Wolfgang Schlegel; M F Wannenmacher
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):164-70.
2000: Klaus K Herfarth; Andrea Pirzkall; Frank Lohr; Daniela Schulz-Ertner; J Spoo; Claudia Frank; Malte L Bahner; O Pastyr; Jürgen Debus
[First experiences with a noninvasive patient set-up system for radiotherapy of the prostate].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(5):217-22.
2000: Klaus K Herfarth; Jürgen Debus; Frank Lohr; Malte L Bahner; P Fritz; Angelika Höss; Wolfgang Schlegel; M F Wannenmacher
Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases.
International journal of radiation oncology, biology, physics 2000;46(2):329-35.
1999: Frank Lohr; Jürgen Debus; Claudia Frank; Klaus K Herfarth; O Pastyr; Bernhard Rhein; Malte L Bahner; Wolfgang Schlegel; Michael Wannenmacher
Noninvasive patient fixation for extracranial stereotactic radiotherapy.
International journal of radiation oncology, biology, physics 1999;45(2):521-7.